JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P 500 Value ETF
IVE
|
+$2.05B |
| 2 |
iShares S&P 500 Growth ETF
IVW
|
+$1.92B |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.13B |
| 4 |
iShares Russell 1000 Value ETF
IWD
|
+$1.1B |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$1.06B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.24B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.12B |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$989M |
| 4 |
Microsoft
MSFT
|
+$973M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$931M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.54% |
| 2 | Technology | 14.97% |
| 3 | Healthcare | 10.91% |
| 4 | Financials | 10.87% |
| 5 | Consumer Discretionary | 8.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3026
Graham Corp
GHM
$1.04B
| $1.47M | ﹤0.01% |
114,091
+2,401
| +2% | +$41.7K |
2015 Q4
17 quarters
|
|
3027
State Street SPDR S&P Metals & Mining ETF
XME
$4.29B
| $1.47M | ﹤0.01% |
91,132
-50,804
| -36% | -$1.18M |
2015 Q4
17 quarters
|
|
3028
PUT
Accenture
ACN
$118B
| $1.47M | ﹤0.01% |
9,000
-16,100
| -64% | -$3.1M |
2019 Q2
3 quarters
|
|
|
UNVR
3029
DELISTED
Univar Solutions Inc.
UNVR
| $1.47M | ﹤0.01% |
136,872
+12,828
| +10% | +$238K |
2019 Q1
4 quarters
|
|
3030
CALL
Cadence Design Systems
CDNS
$99B
| $1.47M | ﹤0.01% |
+22,200
| New | +$1.54M |
2020 Q1
0 quarters
|
|
3031
SunCoke Energy
SXC
$852M
| $1.46M | ﹤0.01% |
380,133
+242,460
| +176% | +$1.23M |
2013 Q2
27 quarters
|
|
3032
iShares US Financial Services ETF
IYG
$2.11B
| $1.46M | ﹤0.01% |
42,612
-10,398
| -20% | -$475K |
2016 Q1
16 quarters
|
|
|
NID
3033
DELISTED
NUVEEN INTERMEDIATE DURATION MUNICIPAL TERM FUND
NID
| $1.46M | ﹤0.01% |
112,252
+109,068
| +3,426% | +$1.5M |
2019 Q4
1 quarter
|
|
3034
OrthoPediatrics
KIDS
$593M
| $1.46M | ﹤0.01% |
36,727
+14,387
| +64% | +$645K |
2017 Q4
9 quarters
|
|
|
ZUO
3035
DELISTED
Zuora, Inc.
ZUO
| $1.46M | ﹤0.01% |
180,964
+35,662
| +25% | +$469K |
2018 Q2
7 quarters
|
|
|
BRFS
3036
DELISTED
BRF SA
BRFS
| $1.45M | ﹤0.01% |
501,276
+362,369
| +261% | +$2.28M |
2013 Q2
27 quarters
|
|
3037
Amplify Mobile Payments ETF
IPAY
$150M
| $1.45M | ﹤0.01% |
39,017
| – | – |
2018 Q4
5 quarters
|
|
|
AVTR.PRA
3038
DELISTED
Avantor, Inc. Series A Mandatory Convertible Preferred Stock
AVTR.PRA
| $1.45M | ﹤0.01% |
33,424
-32,483
| -49% | -$1.83M |
2019 Q3
2 quarters
|
|
|
AVNS
3039
DELISTED
Avanos Medical
AVNS
| $1.45M | ﹤0.01% |
53,799
-7,107
| -12% | -$212K |
2014 Q4
21 quarters
|
|
3040
Precision BioSciences
DTIL
$171M
| $1.45M | ﹤0.01% |
8,002
+4,872
| +156% | +$1.28M |
2019 Q1
4 quarters
|
|
|
MTEM
3041
DELISTED
Molecular Templates, Inc.
MTEM
| $1.45M | ﹤0.01% |
7,265
+6,893
| +1,853% | +$1.51M |
2017 Q3
10 quarters
|
|
3042
Zillow
ZG
$6.38B
| $1.45M | ﹤0.01% |
+42,613
| New | +$1.95M |
2020 Q1
0 quarters
|
|
3043
PUT
Bath & Body Works
BBWI
$3.62B
| $1.45M | ﹤0.01% |
154,625
+40,821
| +36% | +$648K |
2017 Q1
12 quarters
|
|
3044
ATN International
ATNI
$437M
| $1.44M | ﹤0.01% |
24,522
+9,448
| +63% | +$535K |
2016 Q2
15 quarters
|
|
3045
MarineMax
HZO
$1.16B
| $1.44M | ﹤0.01% |
138,095
+67,962
| +97% | +$1.11M |
2017 Q4
9 quarters
|
|
3046
First Trust Utilities AlphaDEX Fund
FXU
$744M
| $1.44M | ﹤0.01% |
58,501
+704
| +1% | +$20K |
2018 Q1
8 quarters
|
|
|
CRHM
3047
DELISTED
CRH Medical Corporation
CRHM
| $1.43M | ﹤0.01% |
1,064,553
-71,100
| -6% | -$232K |
2017 Q2
11 quarters
|
|
3048
Alaunos Therapeutics
TCRT
$1.89M
| $1.43M | ﹤0.01% |
3,880
+2,283
| +143% | +$1.18M |
2016 Q4
13 quarters
|
|
3049
Heartland Express
HTLD
$876M
| $1.42M | ﹤0.01% |
76,614
+28,373
| +59% | +$539K |
2013 Q2
27 quarters
|
|
3050
Renasant Corp
RNST
$3.6B
| $1.42M | ﹤0.01% |
65,171
+15,477
| +31% | +$459K |
2016 Q4
13 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2020 Portfolio in Review
As of Q1 2020, JP Morgan Chase held 6,012 positions worth $426B, down 21% from $536B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase deployed $14B of net new capital in Q1 2020, opening 362 new positions and adding to 2,382 existing holdings. Its largest new stake was NextEra Energy, Inc. 5.279% Corporate Units: 1,245,017 shares worth $54.9M.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was JPMorgan BetaBuilders Japan ETF, an estimated $1.24B trimmed.
- JP Morgan Chase's largest Q1 2020 buy was NextEra Energy, Inc. 5.279% Corporate Units: 1,245,017 shares worth $54.9M.
- JP Morgan Chase added most to iShares S&P 500 Value ETF in Q1 2020, an estimated $2.05B increase.
- JP Morgan Chase's biggest Q1 2020 reduction was JPMorgan BetaBuilders Japan ETF, cutting an estimated $1.24B.
- JP Morgan Chase fully exited Liberty Property Trust in Q1 2020, selling an estimated $264M.
- JP Morgan Chase's ten largest holdings make up 18% of its $426B portfolio in Q1 2020.
- JP Morgan Chase opened 362 new positions and closed 692 in Q1 2020.
- JP Morgan Chase's portfolio value fell 21% quarter-over-quarter to $426B.
Based on JP Morgan Chase's 13F filing for Q1 2020, filed 12 May 2020.